Palmitoyl Tetrapeptide-20 (PTP20) is studied for hair pigmentation through α-MSH-related signaling, melanogenesis-related pathways and oxidative-stress mechanisms involving catalase and hydrogen peroxide. This article explains how PTP20 is thought to work: the pigmentation pathway it is associated with, the three main mechanisms described in ingredient research, what in vitro, ex vivo and human studies can and cannot show, and why formulation quality still decides the outcome. PTP20 is a cosmetic ingredient for formulation development, not a drug and not a hair dye. For a general introduction to Palmitoyl Tetrapeptide-20, including its available forms and sourcing considerations, see What Is Palmitoyl Tetrapeptide-20?
Why Does Hair Turn Gray?
Hair color comes from melanin produced by melanocytes in the hair bulb. As the hair shaft grows, melanin is transferred into the keratinocytes that form the shaft, and this is what gives hair its visible color. Hair graying (canities) is generally associated with three overlapping changes: a reduction in melanin production, a decline in active melanocyte function, and an increase in oxidative stress in the follicle and hair shaft. Age and genetics play the dominant role in when and how quickly these changes occur.
It is also important to distinguish early gray from fully white hair. Premature graying involves hair that is still growing with some residual pigmentation capacity, while fully white hair is more often associated with follicles where melanocyte activity has largely ceased. These are different biological situations, and no responsible cosmetic claim treats them the same way. Because pigment is deposited as the hair shaft forms, any pigmentation-related ingredient is discussed in the context of new hair growth cycles rather than the existing hair shaft.
The α-MSH and MC1-R Pigmentation Pathway
The interest in PTP20 starts with α-melanocyte-stimulating hormone (α-MSH), a peptide involved in the regulation of pigmentation. In the skin and hair follicle, α-MSH binds to the melanocortin-1 receptor (MC1-R) on melanocytes. MC1-R signaling sits upstream of melanin synthesis: it influences how melanocytes respond to pigment-related signals, and it is a widely studied axis in pigment biology.
PTP20 was designed as a biomimetic (α-MSH-like) peptide, which means its research interest lies in the same signaling direction as α-MSH. This is why ingredient documentation and published studies associate PTP20 with MC1-R and pigmentation-related pathways, rather than with coloring the hair shaft directly.
Step 1 - Supporting Melanin Synthesis
Melanin synthesis is the first step in pigmentation: melanocytes produce melanin pigments inside specialized organelles. In research related to PTP20, the peptide is studied in connection with markers associated with melanogenesis. The published 2018 study reported that PTP20 was associated with increased expression of melanogenesis-related markers such as MC1-R and TRP-1 in the models examined.
This is a mechanism-level observation, not a claim of human efficacy. Formulation language should stay within what the data support-for example, "studied in relation to melanogenesis-related pathways"-rather than implying that the ingredient restores lost pigmentation on its own.
Step 2 - Melanosome Transfer as a Related Research Direction
Melanin synthesis and melanin transfer are not the same process. After melanin is produced, it must be transferred from melanocytes to the keratinocytes that form the growing hair shaft. This transfer step contributes to pigmentation of newly forming hair.
Melanosome transfer is described in technical literature for specific PTP20-related commercial systems as one of the pigmentation pathways of interest. However, data generated for a branded complex should not automatically be attributed to every generic Palmitoyl Tetrapeptide-20 powder or formulation. Buyers and formulators should evaluate evidence for the exact supplied material.
Step 3 - Catalase Activity and Hydrogen Peroxide
The third research axis is oxidative stress. Low levels of hydrogen peroxide (H2O2) are produced during normal cellular metabolism, and catalase is an enzyme that helps break H2O2 down. In the hair follicle, the accumulation of H2O2 and other reactive oxygen species is associated with increased oxidative stress, which is one of the mechanisms studied in relation to graying.
PTP20 research examined this axis directly. In the 2018 study, treatment was associated with increased catalase expression and reduced intracellular hydrogen peroxide (by about 30% in the studied model). Official ingredient documentation for the branded PTP20-based system Greyverse™ lists melanin synthesis, melanosome transfer and improved catalase activity among its main research directions. These are reported research observations; they do not by themselves prove a consumer-visible effect.
What Do In Vitro, Ex Vivo and Human Studies Mean?
Different study types answer different questions, and it is easy to overstate their meaning. The table below summarizes what each can and cannot show.
| Evidence Type | What It Can Show | What It Cannot Show |
|---|---|---|
| In vitro | Cell-level pathways and molecular signaling | Consumer-visible effects |
| Ex vivo | Follicle or tissue-level behavior | Long-term human results |
| Human evaluation | Appearance-related changes under a specific formula and test condition | That the same result applies to every raw material or formula |
The main published PTP20 study combined all three levels: in vitro experiments on human follicle dermal papilla cells, ex vivo work on human micro-dissected hairs, and a clinical observation in 15 male volunteers with premature graying who applied a lotion containing 10 ppm PTP20 daily for three months. The human arm is small and tied to a specific formula; results from a single ingredient study should not be extrapolated to any finished product.
Can PTP20 Reverse Gray Hair?
No. PTP20 should not be presented as a treatment that restores all gray hair, and it should not be used with absolute claims such as "permanently reverses gray hair," "cures premature graying" or "clinically proven for everyone." For follicles where melanocyte activity has largely ceased (fully white hair), no responsible claim should make a definite commitment.
The appropriate framing is cosmetic: "supports hair pigmentation-related formulations," "designed for anti-gray hair care development," "helps support the appearance of naturally pigmented hair" and "studied for melanogenesis and oxidative-stress-related pathways." The current evidence suggests a mechanism of action and an early clinical observation in a small cohort; it is not a guarantee of outcome.
Why Formulation Quality Still Matters
A peptide is only as useful as its finished formula. Several factors decide whether PTP20 performs in a real product:
- Ingredient identity: full peptide sequence, terminal form (free peptide, amide or salt) and molecular weight confirmation.
- Actual peptide content and active basis, not just bottle weight.
- Stability in the intended vehicle over time and at processing temperature.
- Product contact time: leave-on formats provide extended scalp contact, which is why they are common carriers for low-dose actives.
- Packaging that protects the formula from light, air and contamination.
- Consistent daily use over the relevant period.
- Finished-product efficacy verification, because ingredient-level data do not predict formula-level results.
FAQ
Does PTP20 activate MC1-R?
PTP20 is designed as an α-MSH biomimetic peptide and is studied in relation to the MC1-R pathway. This is a research association based on signaling models, not a claim of a guaranteed receptor response in every person.
Does it reduce hydrogen peroxide?
Published research reported reduced intracellular hydrogen peroxide and increased catalase expression in the studied model. This is an experimental observation, not a guarantee of a specific effect in every formulation.
Does it color existing hair shafts?
No. PTP20 is not a dye. It does not color the hair shaft; it is studied in relation to pigmentation-related pathways during new hair growth.
Is it suitable for early gray or fully white hair?
It is positioned for early-gray and hair-pigmentation-related care. For fully white hair associated with largely inactive melanocytes, no responsible claim makes a definite promise.
How strong is the current evidence?
The current evidence is a single peer-reviewed dataset combining in vitro, ex vivo and a small human observation. It points to a mechanism of action; larger, higher-quality studies are still needed.
References
- Almeida Scalvino S, et al. Efficacy of an agonist of α-MSH, the palmitoyl tetrapeptide-20, in hair pigmentation. International Journal of Cosmetic Science. 2018;40(5):516–524.
- PubMed – Palmitoyl Tetrapeptide-20 hair pigmentation study, PMID 30222197. https://pubmed.ncbi.nlm.nih.gov/30222197/
- COSMILE Europe – Palmitoyl Tetrapeptide-20 cosmetic ingredient information.
- Clariant / Lucas Meyer Cosmetics – Greyverse™ product information.
Contact HDM Biotech
Looking for Palmitoyl Tetrapeptide-20 powder for cosmetic formulation research? HDM Biotech provides batch-specific COA, analytical documentation, sample support and bulk supply options according to the confirmed product specification.
WhatsApp: +8619991242181
Email:sales@hdmbio.com